vaccine stocks news - Search News

Vaccine Stocks Jump

Wall Street Journal · 1d

Vaccine Stocks Jump on U.S. Bird-Flu Death

Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first American death caused by the H5N1 bird flu. Moderna and Novavax shares rose more than 10%,

Hosted on MSN · 1d

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

On Monday, the U.S. Centers for Disease Control and Prevention (“CDC”) reported the first human death in the country from the H5N1 virus, also known as bird flu. Despite the death, CDC believes that the risk to the general public remains low due to a lack of evidence of human-to-human transmission.

Markets Insider on MSN · 1d

Moderna and other vaccine maker shares jump after first US bird flu death

Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its first death from the virus.

Finbold | Finance in Bold1d

Here’s why vaccine stocks are surging in 2025

Vaccine stocks received a major and sudden boost on January 7, 2025. Here's why these companies are experiencing tailwinds in ...

Zacks.com on MSN5h

Expanding Global Network, Vaccine Sales Support PAHC Stock

Phibro Animal Health's PAHC diversified product portfolio and wide presence in key growth areas bolster our confidence in the ...

1d

Why Did Moderna Stock Rise 12%?

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

1d

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

1don MSN

Prediction: These Could Be the Best-Performing Value Stocks Through 2030

Value stocks have lagged well behind growth stocks in recent years. D.R. Horton (NYSE: DHI) is the largest homebuilder in the ...

10d

25 Worst Stocks to Own in January

The equity is pulling back slightly today, though it remains well above its Nov. 15 dip to $24.48 -- its lowest mark since ...

2d

Wuxi Biologics to sell Irish vaccine facility to Merck for $500M, Reuters says

Wuxi Biologics (WXXWY) plans to sell its Irish vaccine facility to Merck (MRK) for around $500M ahead of potential U.S. legislation that would ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results